Conversant Bio Overview

  • Founded

  • 2006

Founded
  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • Merger of Eq.

  • Financing Rounds

  • 1

  • Investments

  • 2

Conversant Bio General Information

Description

Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procurement of human primary cells from peripheral blood, bone marrow, processed and whole tissue as well as assessment of tumor tissues for scientific investigations, enable clients to develop new medicines and diagnostic tools.

Contact Information

Website
www.conversantbio.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Acquirer
Discovery Life Sciences
Primary Office
  • 601 Genome Way
  • Suite 1200
  • Huntsville, AL 35806
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conversant Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conversant Bio‘s full profile, request access.

Request a free trial

Conversant Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biospecimen services intended for oncology and rheumatology research. The company's services including procu
Laboratory Services (Healthcare)
Huntsville, AL
00000000000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Folsom, CA
000000000 -

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000000
Littleton, MA
00 As of 0000
000.00
000000000. 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Conversant Bio Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
StemExpress Corporation Folsom, CA 000000000 -
000000 0000 Accelerator/Incubator Backed Littleton, MA 00 000.00 000000000. 0 000.00
0000 000000000000 Corporation San Diego, CA 0 000000000 -
000000 0000000000 Formerly PE-Backed Nottingham, United Kingdom 0 000.00 00000000000 000.00
00000000 000000000 Private Debt Financed Vancouver, Canada 0000 000.00 00000000. 00 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Conversant Bio Patents

  • 1

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Conversant Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060101063-A1 Method for the collection and analysis of medical data Abandoned 05-Nov-2004 000000000 0

Conversant Bio Executive Team (4)

Name Title Board Seat Contact Info
Will Taylor Chief Financial Officer
Jay Scherer Chief Operating Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Conversant Bio Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 24-Mar-2015 00000 0000 Clinics/Outpatient Services 00000000
Entopsis 18-Mar-2015 Seed Round 00000 Diagnostic Equipment
To view Conversant Bio’s complete investments history, request access »